002118SZSE

Announcement on Severe Abnormal Fluctuations in Company Stock Trading

*ST Zixin Co., Ltd.·June 7, 2023·3 pages

✨ AI Summary

This announcement addresses significant abnormal fluctuations in the stock price of Jilin Zixin Pharmaceutical Co., Ltd., which saw a cumulative decline of 13.53% over three days. The company confirmed no undisclosed information affecting stock trading and reiterated its commitment to transparent disclosure. Investors are cautioned about potential risks related to the company's financial situation and ongoing investigations by regulatory authorities.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 002118
Securities Abbreviation: *ST Zixin
Announcement Number: 2023-076

Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "the Company") announces that the Board of Directors guarantees that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

I. Introduction to Severe Abnormal Fluctuations in Stock Trading

The Company experienced a cumulative decline of 13.53% in closing prices over three consecutive trading days on June 5, 6, and 7, 2023. The stock exhibited abnormal trading fluctuations in the same direction four times within ten consecutive trading days, which, according to the relevant provisions of the Shenzhen Stock Exchange Trading Rules, constitutes severe abnormal fluctuations in stock trading.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.